Works matching IS 2574173X AND DT 2022 AND VI 42 AND IP 2
Results: 20
COVID‐19 vaccination did not improve employee mental health: A prospective study in an early phase of vaccination in Japan.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 230, doi. 10.1002/npr2.12250
- By:
- Publication type:
- Article
Role of noradrenergic transmission within the ventral bed nucleus of the stria terminalis in nicotine withdrawal‐induced aversive behavior.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 233, doi. 10.1002/npr2.12252
- By:
- Publication type:
- Article
Relationship between autistic traits and social functioning in healthy individuals.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 226, doi. 10.1002/npr2.12249
- By:
- Publication type:
- Article
A 12‐session relapse prevention program vs psychoeducation in the treatment of Japanese alcoholic patients: A randomized controlled trial.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 205, doi. 10.1002/npr2.12248
- By:
- Publication type:
- Article
Clinical characteristics and treatment outcomes of patients with newly diagnosed schizophrenia: A 4‐year single‐center experience in Saudi Arabia.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 199, doi. 10.1002/npr2.12247
- Publication type:
- Article
Development of attentional networks during childhood and adolescence: A functional MRI study.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 191, doi. 10.1002/npr2.12246
- By:
- Publication type:
- Article
Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 221, doi. 10.1002/npr2.12245
- By:
- Publication type:
- Article
Efficacy of clozapine for long‐stay patients with treatment‐resistant schizophrenia: 4‐year observational study.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 183, doi. 10.1002/npr2.12244
- By:
- Publication type:
- Article
Retention and impairment of neurocognitive functions in mild cognitive impairment and Alzheimer's disease with a comprehensive neuropsychological test.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 174, doi. 10.1002/npr2.12243
- By:
- Publication type:
- Article
Association between psychotropic prescriptions and the total amount of psychotropics ingested during an intentional overdose: A single‐center retrospective study.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 166, doi. 10.1002/npr2.12242
- By:
- Publication type:
- Article
Effectiveness of progressive muscle relaxation technique on anxiety caused by Covid‐19 in pregnant women: A randomized clinical trial.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 158, doi. 10.1002/npr2.12241
- By:
- Publication type:
- Article
Aripiprazole LAI two‐injection start in a 16 year‐old adolescent with schizophrenia.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 241, doi. 10.1002/npr2.12240
- By:
- Publication type:
- Article
Multisectoral actions of mental health during the COVID‐19 pandemic in Mazandaran province of Iran.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 148, doi. 10.1002/npr2.12239
- By:
- Publication type:
- Article
A case report: Clozapine‐induced leukopenia and neutropenia after mRNA COVID‐19 vaccination.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Psychological stress of emergency medical staff after the largest mass murder incident in post‐World War II era.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 142, doi. 10.1002/npr2.12237
- By:
- Publication type:
- Article
Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 218, doi. 10.1002/npr2.12236
- By:
- Publication type:
- Article
Safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease—Results of a multicenter open trial.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 135, doi. 10.1002/npr2.12235
- By:
- Publication type:
- Article
Evaluation of a natural S‐equol supplement in treating premenstrual symptoms and the effect of the gut microbiota: An open‐label pilot study.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 127, doi. 10.1002/npr2.12234
- By:
- Publication type:
- Article
Alfaxalone improved in acute stress‐induced tactile hypersensitivity and anxiety‐like behavior in mice.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 213, doi. 10.1002/npr2.12233
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 125, doi. 10.1002/npr2.12185
- Publication type:
- Article